Perceptive Advisors – NEUROCRINE BIOSCIENCES INC

Perceptive Advisors ownership history of NEUROCRINE BIOSCIENCES INC
QuarterValueSharesWeighting
Q1 2021$183,186
0.6%
1,883,664
-0.8%
1.16%
-40.8%
Q4 2020$182,040
22.2%
1,899,215
22.6%
1.95%
-10.1%
Q3 2020$148,924
-43.0%
1,548,715
-27.7%
2.17%
-48.6%
Q2 2020$261,252
-1.5%
2,141,410
-30.1%
4.23%
-38.7%
Q1 2020$265,126
-31.7%
3,063,263
-15.2%
6.90%
-10.5%
Q4 2019$388,313
6.1%
3,612,554
-11.0%
7.71%
-21.7%
Q3 2019$365,837
7.7%
4,059,900
0.9%
9.86%
26.4%
Q2 2019$339,734
2.6%
4,023,862
7.1%
7.80%
-16.6%
Q1 2019$331,138
5.0%
3,758,662
-18.4%
9.34%
-22.2%
Q4 2018$315,363
-46.3%
4,608,554
-3.5%
12.00%
-23.6%
Q3 2018$587,363
26.8%
4,777,254
1.3%
15.71%
29.3%
Q2 2018$463,226
17.3%
4,715,250
-1.0%
12.14%
9.8%
Q1 2018$394,912
-1.2%
4,761,989
-7.6%
11.06%
-16.5%
Q4 2017$399,712
-31.9%
5,151,589
-46.2%
13.25%
18.2%
Q3 2017$587,258
256.8%
9,583,178
167.9%
11.21%
35.4%
Q2 2017$164,569
12.9%
3,577,589
6.3%
8.28%
-0.3%
Q1 2017$145,771
13.6%
3,366,530
1.5%
8.30%
-9.0%
Q4 2016$128,349
2.4%
3,316,523
33.9%
9.13%
12.8%
Q3 2016$125,398
-1.4%
2,476,272
-11.5%
8.09%
-8.2%
Q2 2016$127,167
18.2%
2,797,967
2.8%
8.82%
-6.6%
Q1 2016$107,614
-23.8%
2,720,967
9.0%
9.44%
-9.6%
Q4 2015$141,208
-39.7%
2,496,167
-57.6%
10.45%
11.6%
Q3 2015$234,202
49.3%
5,885,934
79.2%
9.36%
-0.9%
Q2 2015$156,866
5.6%
3,284,467
-12.2%
9.45%
-18.2%
Q1 2015$148,566
28.7%
3,741,267
-27.6%
11.54%
19.3%
Q4 2014$115,392
41.1%
5,165,267
-1.0%
9.68%
10.2%
Q3 2014$81,771
19.8%
5,218,267
13.4%
8.78%
31.1%
Q2 2014$68,262
-8.2%
4,599,867
-0.4%
6.70%
-14.3%
Q1 2014$74,372
90.3%
4,619,367
10.4%
7.82%
66.5%
Q4 2013$39,076
-62.2%
4,183,737
-54.1%
4.69%
10.4%
Q3 2013$103,242
43.4%
9,120,408
69.5%
4.25%
-41.5%
Q2 2013$72,0075,381,7177.26%